Mingming Xu

机构：Third People's Hospital of Hangzhou · ORCID：0009-0007-4167-3729

发表论文 6 篇 · 总被引 47 次 · h-index 3

代表论文

• The systemic inflammation markers as possible indices for predicting respiratory failure and outcome in patients with myasthenia gravis (2022 · Annals of Clinical and Translational Neurology · 被引 31)
• The Role of Gut Microbiota in Male Erectile Dysfunction of Rats (2024 · The World Journal of Men s Health · 被引 9)
• Circulating miRNAs drive personalized medicine based on subgroup classification in myasthenia gravis patients (2023 · Neurological Sciences · 被引 3)
• Plasma C18 :0‐ceramide is a novel potential biomarker for disease severity in myasthenia gravis (2023 · Journal of Neurochemistry · 被引 3)
• Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐ AChR Antibody‐Positive Myasthenia Gravis: FGF ‐19 as a Novel Biomarker (2025 · Annals of Clinical and Translational Neurology · 被引 1)
• The Systemic Inflammation Markers as Possible Indexes of Poor Prognosis in Patients with Myasthenia Gravis (2022 · SSRN Electronic Journal)